Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYourgene Regulatory News (YGEN)

Share Price Information for Yourgene (YGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: 0.50 (2.94%)
Spread: 1.00 (5.88%)
Open: 17.50
High: 17.75
Low: 17.00
Yest. Close: 17.00
YGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Yourgene Health PLC - Result of AGM

Tue, 17th Sep 2019 17:50

RNS Number : 6796M
Yourgene Health PLC
17 September 2019
 

 

Yourgene Health plc

("Yourgene" or the "Company")

 

Result of AGM

 

Manchester, UK - 17 September 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that, at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

 

Details of the proxy votes received from shareholders on each resolution will be available on the Company's website: https://www.yourgene-health.com/investors/key-documents/shareholder-communications 

 

 

 

Yourgene Health plc

Lyn Rees, Chief Executive Officer

Barry Hextall, Chief Financial Officer

Joanne Cross, Director of Marketing

 

 

Tel: +44 (0)161 667 1053

investors@yourgene-health.com

 

Cairn Financial Advisers LLP (NOMAD)

Liam Murray / James Caithie / Ludovico Lazzaretti

 

 

Tel: +44 (0)20 7213 0880

Stifel Nicolaus Europe Limited (Sole Corporate Broker)

Nicholas Moore / Matthew Blawat / Ben Maddison

 

Tel: +44 (0)20 7710 7600

Walbrook PR Ltd (Media and Investor Relations)

Paul McManus / Lianne Cawthorne / Anna Dunphy

 

Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com

Mob: 07980 541 893 / 07584 391 303 / 07876 741 001

 

 

 

About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. 

 

Yourgene develops and commercialises simple and accurate molecular diagnostic solutions, primarily for reproductive health. The Group's products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, male infertility tests and genetic disease tests. Yourgene's commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.

 

Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions. Through our technical expertise and partnerships, Yourgene Health is also extending its genetic testing offering into oncology.

 

Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information, visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGCKODQABKDFCD
Date   Source Headline
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test

Login to your account

Don't have an account? Click here to register.